The table below summarizes the most recent ELGX insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why ELGX insider buys are important for investors to follow.

Date	Insider	Price	Amount
4-3-2019 Insider Buy	Thomas F. Zenty III Director	$6.61 CAGR »	$19,995.25 3,025 shares
5-19-2017 Insider Buy	John D. McDermott Chief Executive Officer	$4.45 CAGR »	$111,250.00 25,000 shares
5-22-2017 Insider Buy	Thomas F. Zenty III Director	$4.44 CAGR »	$22,200.00 5,000 shares
5-19-2017 Insider Buy	Guido J. Neels Director	$4.32 CAGR »	$86,400.00 20,000 shares
5-19-2017 Insider Buy	Robert D. Mitchell President	$4.32 CAGR »	$9,504.00 2,200 shares
12-13-2016 Insider Buy	Vaseem Mahboob Chief Financial Officer	$6.25 CAGR »	$125,000.00 20,000 shares
12-14-2016 Insider Buy	John D. McDermott Chief Executive Officer	$6.67 CAGR »	$66,710.00 10,000 shares
12-14-2016 Insider Buy	Thomas F. Zenty III Director	$6.51 CAGR »	$19,530.00 3,000 shares
11-18-2016 Insider Buy	Guido J. Neels Director	$7.69 CAGR »	$99,970.00 13,000 shares
11-18-2016 Insider Buy	Thomas F. Zenty III Director	$7.89 CAGR »	$23,670.00 3,000 shares
11-3-2015 Insider Buy	Guido J. Neels Director	$9.32 CAGR »	$102,520.00 11,000 shares
11-3-2015 Insider Buy	Todd Abraham VP of Operations	$8.85 CAGR »	$22,125.00 2,500 shares
11-2-2015 Insider Buy	John D. McDermott Chief Executive Officer	$8.90 CAGR »	$178,000.00 20,000 shares
11-18-2014 Insider Buy	Charles Steele Love VP-Clinical Affairs	$11.70 CAGR »	$23,392.16 2,000 shares
11-4-2014 Insider Buy	John D. McDermott Chief Executive Officer	$11.25 CAGR »	$281,250.00 25,000 shares
2-25-2011 Insider Buy	Todd Abraham VP of Operations	$5.80 CAGR »	$29,000.00 5,000 shares

Also See: Institutional Holders of ELGX
Also See: SEC filings

Below we present the annualized performance delivered by ELGX stock since 4-3-2019 (the date of the most recent insider purchase). The performance of the investment from the time ELGX insider buying occurred is the ultimate test of whether insiders were right about ELGX being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	04/04/2019
End date:	07/15/2020
Start price/share:	$7.00
End price/share:	$0.22
Dividends collected/share:	$0.00
Total return:	-96.86%
Average Annual Total Return:	-93.27%
Starting investment:	$10,000.00
Ending investment:	$314.26
Years:	1.28

ELGX Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ELGX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ELGX

ELGX — Current Quote

Quotes delayed 20 minutes

Free ELGX Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

ELGX — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the ELGX Insider Buying occurred are:

AERI Insider Buying
WTR Insider Buying
MIK Insider Buying
RARE Insider Buying
PGNX Insider Buying
VSTR Insider Buying
PRGX Insider Buying
CBAK Insider Buying
CSL Insider Buying
FSB Insider Buying

ELGX Insider Buying

ELGX Insider Buying | www.HoldingsChannel.com